1h Free Analyst Time
Global Cell Viability Assays Market 2020-2024Speak directly to the analyst to clarify any post sales queries you may have.
The publisher has been monitoring the global cell viability assays market and it is poised to grow by USD 1.40 bn during 2020-2024, progressing at a CAGR of 8% during the forecast period. The report on the global cell viability assays market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by growing emphasis on timely diagnosis of diseases. In addition, growing focus on stem cell research is anticipated to boost the growth of the global cell viability assays market as well.
Market Segmentation
Global cell viability assays market is segmented as below:
Product:
- Consumables
- Instruments
Geographic Segmentation:
- North America
- APAC
- Europe
- South America
- MEA
Key Trends for the global cell viability assays market growth
This study identifies growing focus on stem cell research as the prime reasons driving the global cell viability assays market growth during the next few years.
Prominent vendors in global cell viability assays market
The publisher provides a detailed analysis of around 25 vendors operating in the global cell viability assays market, including some of the vendors such as Agilent Technologies Inc., Becton, Dickinson and Co., Bio-Rad Laboratories Inc., Biotium Inc., Danaher Corp., General Electric Co., Merck KGaA, PerkinElmer Inc., Promega Corp. and Thermo Fisher Scientific Inc. .
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Table of Contents
PART 01: EXECUTIVE SUMMARYPART 07: CUSTOMER LANDSCAPEPART 09: DECISION FRAMEWORK
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
PART 04: MARKET SIZING
PART 05: FIVE FORCES ANALYSIS
PART 06: MARKET SEGMENTATION BY PRODUCT
PART 08: GEOGRAPHIC LANDSCAPE
PART 10: DRIVERS AND CHALLENGES
PART 11: MARKET TRENDS
PART 12: VENDOR LANDSCAPE
PART 13: VENDOR ANALYSIS
PART 14: APPENDIX
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global cell viability assays market: Agilent Technologies Inc., Becton, Dickinson and Co., Bio-Rad Laboratories Inc., Biotium Inc., Danaher Corp., General Electric Co., Merck KGaA, PerkinElmer Inc., Promega Corp. and Thermo Fisher Scientific Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is growing focus on stem cell research."
According to the report, one of the major drivers for this market is the growing emphasis on timely diagnosis of diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Agilent Technologies Inc.
- Becton
- Dickinson and Co.
- Bio-Rad Laboratories Inc.
- Biotium Inc.
- Danaher Corp.
- General Electric Co.
- Merck KGaA
- PerkinElmer Inc.
- Promega Corp.
- Thermo Fisher Scientific Inc.
